Development Of A Scorpion Toxin For Tumour Imaging
Funder
National Health and Medical Research Council
Funding Amount
$529,577.00
Summary
The aim of this project is to develop a tool for visualising tumours during surgery. Surgical removal of tumours remains the foundation of cancer treatment, but the ability to distinguish the margin between cancerous and healthy cells is imprecise. We will explore the potential of a scorpion toxin that selectively targets cancer cells, as a tumour imaging agent. This project has the potential to dramatically enhance patient survival as a result of improving treatments for cancer.
Improving The Assessment Of Brain Tumour Treatment Outcome Using 18F-FDOPA PET-MRI Fusion
Funder
National Health and Medical Research Council
Funding Amount
$660,666.00
Summary
The mortality rate within the first year of diagnosis for high-grade brain tumours is approximately 80%. A major factor contributing to poor outcome measures is the limitation of current neuroimaging techniques. In a novel approach we propose to combine the information available from MRI and PET images to better define the extent of the tumour and provide markers of early treatment response. This improved diagnostic information should improve survival rates.
Towards Predicting Brain Deformations For Image-guided Neurosurgery
Funder
National Health and Medical Research Council
Funding Amount
$304,281.00
Summary
We will significantly improve the efficiency of image-guided neurosurgery for brain tumours by creating a novel system to improve intra-operative visualisation and navigation utilising realistic prediction of brain deformations based on a biomechanical model. The system will create an augmented reality visualisation of the intra-operative configuration of the patient's brain merged with high resolution pre-operative imaging data in order to better localise the tumour and critical healthy tissues ....We will significantly improve the efficiency of image-guided neurosurgery for brain tumours by creating a novel system to improve intra-operative visualisation and navigation utilising realistic prediction of brain deformations based on a biomechanical model. The system will create an augmented reality visualisation of the intra-operative configuration of the patient's brain merged with high resolution pre-operative imaging data in order to better localise the tumour and critical healthy tissues.Read moreRead less
Thrombolysis is a method of dissolving the blood clot that is the cause of the majority of strokes in Australia. The first major trial to demonstrate benefit for this treatment was published some 11 years ago but treatment has not been widely implemented across Australia because of the difficulties in giving treatment within the very tight time window for which treatment is currently approved (patients must get to hospital, be scanned and start treatment within 3 hours of the onset of the stroke ....Thrombolysis is a method of dissolving the blood clot that is the cause of the majority of strokes in Australia. The first major trial to demonstrate benefit for this treatment was published some 11 years ago but treatment has not been widely implemented across Australia because of the difficulties in giving treatment within the very tight time window for which treatment is currently approved (patients must get to hospital, be scanned and start treatment within 3 hours of the onset of the stroke). Other factors which have limited implementation of treatment in Australia are continued debate over the trial data for this treatment as only one of the 5 major trials was positive. In addition, virtually no patients aged over 80 years old were included in the previous trials, and as this age group represents about a third of all stroke in Australia, new data in this age group is required. As a result of the difficulty in giving a treatment within such a tight time window and the ongoing debate about the trial data, few Australians are currently treated and thus the public health impact is negligible. In to change clinical practice, we need reliable data from a large convincing further trial of thrombolysis with the more realistic time window of 6 hours. The Third International Stroke Trial (IST-3) is a large international collaborative effort to determine whether thrombolysis treatment offered to a wider range of patients up to 6 hours from stroke onset results in an increase in long-term independent survival. Data from such a trial is most likely to change clinical practice and lead to an important public health benefit.Read moreRead less
A Study Of The Medial Temporal Lobe In High-risk And Established Schizophrenia Using T2 Relaxometry
Funder
National Health and Medical Research Council
Funding Amount
$358,245.00
Summary
Neurodevelopmental models of schizophrenia suggest that this disorder is associated with a structural brain abnormality present from very early life. This model predicts that brain changes are present before the onset of schizophrenia, and do not change. Our work supports the idea that damage is present from the outset of illness - however, this damage was not evident in a high-risk group of individuals who later developed psychosis. When these patients were rescanned after the onset of the illn ....Neurodevelopmental models of schizophrenia suggest that this disorder is associated with a structural brain abnormality present from very early life. This model predicts that brain changes are present before the onset of schizophrenia, and do not change. Our work supports the idea that damage is present from the outset of illness - however, this damage was not evident in a high-risk group of individuals who later developed psychosis. When these patients were rescanned after the onset of the illness, they exhibited reductions in the volumes of structures that are regarded as critical to the symptoms of schizophrenia. The lack of structural changes in this group before the onset of psychosis may have a number of possible explanations. However, it may be that a number of factors produce the observed changes in the temporal lobe in schizophrenia. Thus, high-risk subjects may have a vulnerability to hippocampal damage that becomes apparent during the transition to psychosis. In order to explore this, our study will examine changes in the hippocampi in three groups of patients, and compare them with matched normal control subjects. The patient groups are: (i) individuals at high-risk, (ii) first-episode psychosis patients and (iii) patients with chronic schizophrenia. The study will rescan the high-risk group to examine hippocampal changes once they have become psychotic. T2 relaxometry is a non-invasive way to examine whether changes in the brain are present in patients with schizophrenia from the outset of illness. T2 will also let us examine the high-risk individuals to see whether such changes are also apparent premorbidly. Using T2 we will be able to examine the nature of these structural changes and assess what processes are in evidence. Our MRI findings present a challenge to the neurodevelopmental hypothesis of schizophrenia. The use of T2 in this study will allow a thorough examination of these findings and will have major implications for this hypothesis.Read moreRead less
DETERMINING THE MECHANISMS LEADING TO LONG-TERM IMPAIRMENT IN VERY PRETERM CHILDREN: THE VIBeS LONGITUDINAL STUDY.
Funder
National Health and Medical Research Council
Funding Amount
$1,061,733.00
Summary
Approximately 50% of children born very preterm will develop significant problems. The objective of this project is to determine the mechanisms leading to these problems. We will do this by assessing at school-age a unique and valuable cohort of very preterm infants (VIBeS cohort) who had state-of-the-art brain scans shortly after birth and neurobehaviour assessments across early childhood. This school-age follow-up will involve repeat brain scans and detailed neuropsychological assessments.
Quantifying The Neurocognitive Impact Of Cannabis Across The Life Span: The Evolution Of Memory Deficits.
Funder
National Health and Medical Research Council
Funding Amount
$516,572.00
Summary
Cannabis is the most widely used illicit substance, and its use is particularly prevalent during adolescence and young adulthood. Adolescence is also a period when the brain undergoes significant structural and functional change, and there is growing evidence that the brain may be particularly vulnerable to the effects of addictive substances during this developmental stage. There is increasing evidence that long term or heavy use of cannabis impairs learning and memory. It is thought that the c ....Cannabis is the most widely used illicit substance, and its use is particularly prevalent during adolescence and young adulthood. Adolescence is also a period when the brain undergoes significant structural and functional change, and there is growing evidence that the brain may be particularly vulnerable to the effects of addictive substances during this developmental stage. There is increasing evidence that long term or heavy use of cannabis impairs learning and memory. It is thought that the continued bombardment of the brain s own natural cannabis-like neurotransmitter system by the active chemicals within cannabis disrupts critical aspects of brain function. This research seeks to improve our understanding of the way that cannabis use affects memory and how these problems might develop or worsen from adolescence to adulthood. This project will investigate memory processes in cannabis users using functional brain imaging techniques. This will allow identification of regions of the brain that are not working efficiently when cannabis users attempt to memorise and recall words from a list and recognise patterns. The project will examine how different levels of cannabis use (long term vs. short term and heavy vs. light) may affect brain function during learning and memory, and determine if the observed memory problems depend upon the age at which cannabis use began and the gender of the user. The findings from this research will substantially contribute to our understanding of the ways in which cannabis use affects brain function and potentially triggers serious psychiatric disorders, such as schizophrenia. The findings will contribute to guidelines regarding hazardous levels of cannabis use within adolescent and adult populations, and will inform debate, policy, education and treatment.Read moreRead less